<p>Cardiometabolic outcomes at baseline (mean (standard error (SE))), three and six months for the intervention and control group, unless stated otherwise.</p
Hypertension control at 3 months, stratified by baseline participant characteristics.</p
Outcomes at 12 months follow-up compared between the intervention and the control groups.</p
(A) Percentage change in heart rate relative to baseline, averaged across participants (n = 27). Sha...
<p>Adjusted Means and Standard Errors of Outcome Variables at Baseline, 6-month follow up and 12-mon...
<p>Baseline and cardiac arrest characteristics of the study patients according to neurologic outcome...
<p>Results are mean (SD). Statistics are coefficient of interaction between intervention and time (p...
<p>Outcomes at baseline and 12 months, and linear mixed models-based estimated difference (β) of int...
Primary and secondary outcome measures at baseline and three-month follow-up.</p
<p>Anthropometric and metabolic values at baseline and after a 3 weeks period treatment.</p
<p>n = number of employees; M = Mean; SD = Standard Deviation.</p><p>Means and standard deviation...
<p>Statistical significance: N denotes not significant, *p<0.05, †p<0.01, ‡p<0.001.</p><p>MBMI is th...
<p>Baseline and changes in outcomes variable at 3 months for different BMIs’ populations.</p
<p>Mean, SD values, Mean differences and Confidence Intervals (C.I.) at baseline, 3 months, and 6 mo...
<p>Outcome measure summary statistics and intervention effects at 3, 6, and 12 months.</p
<p>VO<sub>2peak</sub>; peak oxygen uptake, RER<sub>peak</sub>; respiratory exchange ratio at peak ox...
Hypertension control at 3 months, stratified by baseline participant characteristics.</p
Outcomes at 12 months follow-up compared between the intervention and the control groups.</p
(A) Percentage change in heart rate relative to baseline, averaged across participants (n = 27). Sha...
<p>Adjusted Means and Standard Errors of Outcome Variables at Baseline, 6-month follow up and 12-mon...
<p>Baseline and cardiac arrest characteristics of the study patients according to neurologic outcome...
<p>Results are mean (SD). Statistics are coefficient of interaction between intervention and time (p...
<p>Outcomes at baseline and 12 months, and linear mixed models-based estimated difference (β) of int...
Primary and secondary outcome measures at baseline and three-month follow-up.</p
<p>Anthropometric and metabolic values at baseline and after a 3 weeks period treatment.</p
<p>n = number of employees; M = Mean; SD = Standard Deviation.</p><p>Means and standard deviation...
<p>Statistical significance: N denotes not significant, *p<0.05, †p<0.01, ‡p<0.001.</p><p>MBMI is th...
<p>Baseline and changes in outcomes variable at 3 months for different BMIs’ populations.</p
<p>Mean, SD values, Mean differences and Confidence Intervals (C.I.) at baseline, 3 months, and 6 mo...
<p>Outcome measure summary statistics and intervention effects at 3, 6, and 12 months.</p
<p>VO<sub>2peak</sub>; peak oxygen uptake, RER<sub>peak</sub>; respiratory exchange ratio at peak ox...
Hypertension control at 3 months, stratified by baseline participant characteristics.</p
Outcomes at 12 months follow-up compared between the intervention and the control groups.</p
(A) Percentage change in heart rate relative to baseline, averaged across participants (n = 27). Sha...